Craft

Exact Sciences

Stock Price

$70.4

2024-04-01

Market Capitalization

$12.8 B

2024-04-01

Revenue

$2.5 B

FY, 2023

Exact Sciences Summary

Company Summary

Overview
Exact Sciences is a company that provides cancer screening and diagnostic test products. It offers DNA-based colorectal cancer screening, genomic, and breast recurrence score test systems, hepatocellular carcinoma (HCC) detection devices, etc.
Type
Public
Status
Active
Founded
1995
HQ
Madison, WI, US | view all locations
Website
https://www.exactsciences.com
Cybersecurity rating
ESG rating
50-59 out of 100|View all ESG data
Sectors

Key People

  • Kevin Conroy

    Kevin Conroy, Chairman of the Board and CEO

  • Graham Lidgard
  • Pat Setji

    Pat Setji, General Manager, Screening

  • G. Bradley Cole

    G. Bradley Cole, General Manager, Precision Oncology

    Operating MetricsView all

    Testing Services

    6
    14.3%

    FY, 2022

    Facility Space, sq. ft.

    1.8M
    16.4%

    FY, 2022

    LocationsView all

    13 locations detected

    • Madison, WI HQ

      United States

      5505 Endeavor Lane

    • Baltimore, MD

      United States

      1812 Ashland Avenue Suite 640

    • Cambridge, MA

      United States

      222 Jacobs Street, 9th Floor

    • Phoenix, AZ

      United States

      445 N. 5th Street

    • Redwood City, CA

      United States

      101 Galveston Drive

    • Salt Lake City, UT

      United States

      358 S 300 E

    and 7 others

    Exact Sciences Financials

    Summary Financials

    Revenue (FY, 2023)
    $2.5B
    Gross profit (FY, 2023)
    $1.8B
    Net income (FY, 2023)
    ($204.1M)
    Cash (FY, 2023)
    $605.4M
    EBIT (FY, 2023)
    ($215.0M)
    Enterprise value
    $12.2B

    Footer menu